USE OF AURKB SMALL-MOLECULE INHIBITORS FOR TREATMENT OF NON-SMALL CELL LUNG CANCER

摘要

Disclosed is a use of a small-molecule AURKB inhibitor for treatment of non-small cell lung cancer. The small-molecule AURKB inhibitor is directed to a diindolylmethane compound of formula (I) or a stereoisomer, a tautomer, a solvate, a prodrug, a N-oxide or a pharmaceutically acceptable salt thereof.